Adjuvant chemotherapy could improve the survival of pulmonary sarcomatoid carcinoma A systematic review and meta-analysis /
Complete surgical removal is currently considered to be the best treatment option for pulmonary sarcomatoid carcinoma (PSC) especially in early stage operable disease; however, the reported recurrence-free survival is low. Benefits of adjuvant chemotherapy in PSC patients are still controversial, an...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2022
|
| Sorozat: | SURGICAL ONCOLOGY-OXFORD
44 |
| Tárgyszavak: | |
| doi: | 10.1016/j.suronc.2022.101824 |
| mtmt: | 33049438 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/26679 |